P1-IS-41 Final results of a randomized multicenter phase III trial in 505 patients with relapsed ovarian cancer : topotecan monotherapy versus topotecan + etoposide versus topotecan + gemcitabine

Jalid Sehouli, G. Oskay-Özcelik,Alexander Mustea, H. Sommer, Dominique Koensgen,Peter Klare, Martina Stauch, Alain-Gustave Zeimet, A. Paulenz, Theodore L. Steck, Heimo Riedel, E. Keil,Dirk Stengel, Andreas Kuznik, W. Lichtenegger

日本産科婦人科學會雜誌(2007)

引用 23|浏览5
暂无评分
关键词
topotecan monotherapy,ovarian cancer,multicenter phase iii trial
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要